Ozmosi

BEAM is an innovative competitive intelligence tool designed to deliver essential clinical data precisely when and how users need it. Leveraging advanced machine learning and data management techniques, BEAM provides intuitive reporting with dynamic visuals that highlight trends in clinical trials, ensuring users can easily access vital information.

The platform encompasses a comprehensive database of over 500,000 clinical trials from the last 20 years, rendering insights into various patient segments, mechanisms of action, and endpoints. Users benefit from tailored reporting capabilities and can track more than 10,000 pharmaceutical products alongside critical investment metrics like the Risk-Adjusted Value Index Score.

With its unique Point in Time feature, BEAM allows companies to retrieve historical data to refine their investment strategies, especially in the pharmaceutical sector. Backed by OZMOSI's professional services, BEAM is a powerful resource for stakeholders seeking to make informed decisions based on robust, high-quality data. Whether through API integration or customized reporting, BEAM delivers clarity and confidence in navigating the clinical research landscape.